Opendata, web and dolomites

AiPBAND SIGNED

An Integrated Platform for Developing Brain Cancer Diagnostic Techniques

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 AiPBAND project word cloud

Explore the words cloud of the AiPBAND project. It provides you a very rough idea of what is the project "AiPBAND" about.

sectors    stage    innovative    digital    patients    plasmonic    types    business    gliomas    diagnostic    biosensor    people    training    primary    majority    designed    orientated    diagnosis    encourage    framework    achievements    brain    mission    cloud    international    arranged    technologies    academic    creative    economics    generation    local    belonging    proof    maximize    infrastructure    entrepreneurship    neuroscience    mind    sensitivity    events    parallel    progressive    fellows    science    responsible    train    engineering    graphene    beneficiaries    data    medical    devastating    deaths    entrepreneurial    clinical    healthcare    big    experts    elaborately    meeting    biomarkers    multiplex    plans    network    career    blood    private    vitae    secondments    researcher    individual    carefully    personalized    triple    25    societal    trained    ranging    courses    intelligent    esrs    accuracy    fourteen    assay    aipband    trials    elisa    involvement    specificity    tumours    empowered    thinking    transformation    molecular   

Project "AiPBAND" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY OF PLYMOUTH 

Organization address
address: DRAKE CIRCUS
city: PLYMOUTH
postcode: PL4 8AA
website: www.plymouth.ac.uk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Total cost 3˙687˙311 €
 EC max contribution 3˙687˙311 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2017
 Funding Scheme MSCA-ITN-ETN
 Starting year 2018
 Duration (year-month-day) from 2018-01-01   to  2021-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY OF PLYMOUTH UK (PLYMOUTH) coordinator 599˙715.00
2    IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE UK (LONDON) participant 273˙287.00
3    UNIVERSITY COLLEGE LONDON UK (LONDON) participant 273˙287.00
4    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 263˙659.00
5    STOCKHOLMS UNIVERSITET SE (STOCKHOLM) participant 263˙659.00
6    ISTITUTI FISIOTERAPICI OSPITALIERI IT (ROMA) participant 258˙061.00
7    MEDICAL TRIALS ANALYSIS ITALY SRL IT (MILANO) participant 258˙061.00
8    SCRIBA NANOTECNOLOGIE SRL IT (BOLOGNA) participant 258˙061.00
9    UNIVERSITA DEGLI STUDI DI CATANIA IT (CATANIA) participant 258˙061.00
10    THE HYVE BV NL (UTRECHT) participant 255˙374.00
11    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) participant 250˙560.00
12    TEESSIDE UNIVERSITY UK (MIDDLESBROUGH) participant 220˙148.00
13    PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV NL (UTRECHT) participant 198˙624.00
14    STICHTING KATHOLIEKE UNIVERSITEIT NL (NIJMEGEN) participant 56˙749.00
15    B. BRAUN MELSUNGEN AG DE (MELSUNGEN) partner 0.00
16    Beijing Genome Institute CN (BEIJING) partner 0.00
17    Biotecture Ltd NL (Amsterdam) partner 0.00
18    China Capital Medical University CN (Beijing) partner 0.00
19    ENGAGE - KEY TECHNOLOGY VENTURES AG DE (KARLSRUHE) partner 0.00
20    HUNAN UNIVERSITY CN (CHANGSHA) partner 0.00

Map

 Project objective

The mission of AiPBAND is to train a new generation of entrepreneurial and innovative early-stage researchers (ESRs) in the early diagnosis of brain tumours using molecular biomarkers in the blood, meeting the medical and societal challenges of this emerging field. AiPBAND will focus on gliomas, a range of devastating and progressive brain tumours affecting around 25,000 people each year in Europe and responsible for the majority of deaths from primary brain tumours.

Fourteen fellows will be trained by experts in 9 academic and 3 non-academic beneficiaries, belonging to 5 EU member states and 6 partner organizations (4 private sectors and 2 international academic), with fields ranging from neuroscience, engineering (including big data science), healthcare to economics. State-of-the-art technologies will be applied in parallel to (i) identify novel blood biomarkers from patients with gliomas, (ii) design three types of multiplex biosensor (plasmonic-based, graphene-based, and digital ELISA assay-based), (iii) develop a big data-empowered intelligent data management infrastructure, and (iv) develop cloud-based diagnostic systems. Proof-of-concept will be evaluated through clinical trials to assess accuracy, sensitivity and specificity. The elaborately designed individual research projects under the Vitae Researcher Development Framework – carefully arranged into local training courses, network wide events, secondments, personalized career development plans, with strong involvement of the private sector – will ensure exploitation of AiPBAND's achievements, and will maximize the ESRs’ abilities in creative & innovative thinking, triple-i knowledge transformation, and encourage a business-orientated mind-set and entrepreneurship.

 Publications

year authors and title journal last update
List of publications.
2020 Manuela Spagnuolo, Manuela Costantini, Mariaconsiglia Ferriero, Marco Varmi, Isabella Sperduti, Giulia Regazzo, Lucia Cicchillitti, Ana Belén Díaz Méndez, Giovanni Cigliana, Vincenzo Pompeo, Andrea Russo, Valentina Laquintana, Riccardo Mastroianni, Giulia Piaggio, Umberto Anceschi, Aldo Brassetti, Alfredo Bove, Gabriele Tuderti, Rocco Simone Flammia, Michele Gallucci, Giuseppe Simone, Maria Giu
Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study
published pages: , ISSN: 1756-9966, DOI: 10.1186/s13046-020-01550-w
Journal of Experimental & Clinical Cancer Research 39/1 2020-04-24
2019 Noemi Bellassai, Roberta D\'Agata, Vanessa Jungbluth, Giuseppe Spoto
Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis
published pages: , ISSN: 2296-2646, DOI: 10.3389/fchem.2019.00570
Frontiers in Chemistry 7 2020-03-05
2019 Maria Pernemalm, AnnSofi Sandberg, Yafeng Zhu, Jorrit Boekel, Davide Tamburro, Jochen M Schwenk, Albin Björk, Marie Wahren-Herlenius, Hanna Åmark, Claes-Göran Östenson, Magnus Westgren, Janne Lehtiö
In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta
published pages: , ISSN: 2050-084X, DOI: 10.7554/elife.41608
eLife 8 2020-02-13
2019 Vineesh Indira Chandran, Charlotte Welinder, Ann-Sofie Månsson, Svenja Offer, Eva Freyhult, Maria Pernemalm, Sigrid M. Lund, Shona Pedersen, Janne Lehtiö, Gyorgy Marko-Varga, Maria C. Johansson, Elisabet Englund, Pia C. Sundgren, Mattias Belting
Ultrasensitive Immunoprofiling of Plasma Extracellular Vesicles Identifies Syndecan-1 as a Potential Tool for Minimally Invasive Diagnosis of Glioma
published pages: , ISSN: 1078-0432, DOI: 10.1158/1078-0432.ccr-18-2946
Clinical Cancer Research 2020-02-13

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AIPBAND" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "AIPBAND" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

SuperCol (2020)

SuperCol: Rational design of super-selective and responsive colloidal particles for biomedical applications

Read More  

NL4XAI (2019)

Interactive Natural Language Technology for Explainable Artificial Intelligence

Read More  

INSPIRE (2019)

INNOVATIVE GROUND INTERFACE CONCEPTS FOR STRUCTURE PROTECTION

Read More